

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 7.82307753 |
| 2 | actin-myosin filament sliding (GO:0033275) | 7.82307753 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 7.44316656 |
| 4 | actin-mediated cell contraction (GO:0070252) | 6.82278268 |
| 5 | sarcomere organization (GO:0045214) | 6.58668049 |
| 6 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.85697314 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.80846857 |
| 8 | myofibril assembly (GO:0030239) | 5.78231576 |
| 9 | actin filament-based movement (GO:0030048) | 5.21633738 |
| 10 | skeletal muscle contraction (GO:0003009) | 5.16263890 |
| 11 | cardiac myofibril assembly (GO:0055003) | 5.15509704 |
| 12 | regulation of relaxation of muscle (GO:1901077) | 5.09836439 |
| 13 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.93580563 |
| 14 | skeletal muscle adaptation (GO:0043501) | 4.92297708 |
| 15 | regulation of cell communication by electrical coupling (GO:0010649) | 4.84272951 |
| 16 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.81733318 |
| 17 | creatine metabolic process (GO:0006600) | 4.77815403 |
| 18 | actomyosin structure organization (GO:0031032) | 4.67506836 |
| 19 | regulation of actin filament-based movement (GO:1903115) | 4.66961827 |
| 20 | striated muscle contraction (GO:0006941) | 4.62527843 |
| 21 | * response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.54719405 |
| 22 | cardiac muscle contraction (GO:0060048) | 4.40396274 |
| 23 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.38126552 |
| 24 | negative regulation of protein localization to cell surface (GO:2000009) | 4.32728643 |
| 25 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.25216092 |
| 26 | plasma membrane repair (GO:0001778) | 4.24754036 |
| 27 | myotube cell development (GO:0014904) | 4.21796842 |
| 28 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.10565729 |
| 29 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.05622489 |
| 30 | muscle tissue morphogenesis (GO:0060415) | 3.96161460 |
| 31 | regulation of striated muscle contraction (GO:0006942) | 3.85234984 |
| 32 | striated muscle atrophy (GO:0014891) | 3.83668371 |
| 33 | skeletal muscle tissue development (GO:0007519) | 3.83033164 |
| 34 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.78403652 |
| 35 | cardiac muscle cell development (GO:0055013) | 3.77809323 |
| 36 | central nervous system myelination (GO:0022010) | 3.74727917 |
| 37 | axon ensheathment in central nervous system (GO:0032291) | 3.74727917 |
| 38 | muscle contraction (GO:0006936) | 3.70590985 |
| 39 | heart process (GO:0003015) | 3.69103244 |
| 40 | heart contraction (GO:0060047) | 3.69103244 |
| 41 | cardiac cell development (GO:0055006) | 3.68113333 |
| 42 | desmosome organization (GO:0002934) | 3.63369585 |
| 43 | carnitine shuttle (GO:0006853) | 3.63217680 |
| 44 | adult heart development (GO:0007512) | 3.58986063 |
| 45 | cardiac muscle hypertrophy (GO:0003300) | 3.56737304 |
| 46 | striated muscle hypertrophy (GO:0014897) | 3.48978657 |
| 47 | muscle atrophy (GO:0014889) | 3.46035017 |
| 48 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.45979789 |
| 49 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.42840202 |
| 50 | muscle hypertrophy in response to stress (GO:0003299) | 3.42840202 |
| 51 | cardiac muscle adaptation (GO:0014887) | 3.42840202 |
| 52 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.40823724 |
| 53 | muscle system process (GO:0003012) | 3.39801599 |
| 54 | regulation of sarcomere organization (GO:0060297) | 3.39555469 |
| 55 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.39305881 |
| 56 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.32241976 |
| 57 | striated muscle adaptation (GO:0014888) | 3.31091019 |
| 58 | muscle organ development (GO:0007517) | 3.28712895 |
| 59 | response to muscle activity (GO:0014850) | 3.26808965 |
| 60 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.26784236 |
| 61 | myoblast fusion (GO:0007520) | 3.24149496 |
| 62 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.23324652 |
| 63 | hemidesmosome assembly (GO:0031581) | 3.22262106 |
| 64 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.18674911 |
| 65 | glycogen biosynthetic process (GO:0005978) | 3.17804772 |
| 66 | glucan biosynthetic process (GO:0009250) | 3.17804772 |
| 67 | regulation of cardioblast differentiation (GO:0051890) | 3.13841035 |
| 68 | macroautophagy (GO:0016236) | 3.12178343 |
| 69 | eye photoreceptor cell differentiation (GO:0001754) | 3.10624784 |
| 70 | photoreceptor cell differentiation (GO:0046530) | 3.10624784 |
| 71 | glycogen catabolic process (GO:0005980) | 3.08184457 |
| 72 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.05692619 |
| 73 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.05523855 |
| 74 | regulation of cardioblast proliferation (GO:0003264) | 3.04994635 |
| 75 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.04994635 |
| 76 | myotube differentiation (GO:0014902) | 3.04701886 |
| 77 | heart trabecula formation (GO:0060347) | 3.03847830 |
| 78 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.03532393 |
| 79 | * response to inactivity (GO:0014854) | 3.02071476 |
| 80 | positive regulation of myoblast differentiation (GO:0045663) | 2.99995306 |
| 81 | muscle hypertrophy (GO:0014896) | 2.98901175 |
| 82 | muscle fiber development (GO:0048747) | 2.98662994 |
| 83 | muscle cell development (GO:0055001) | 2.97876416 |
| 84 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.97023841 |
| 85 | striated muscle tissue development (GO:0014706) | 2.96042878 |
| 86 | skeletal muscle tissue regeneration (GO:0043403) | 2.93212666 |
| 87 | muscle cell fate commitment (GO:0042693) | 2.92989920 |
| 88 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.92320555 |
| 89 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.92229256 |
| 90 | skeletal muscle fiber development (GO:0048741) | 2.91023239 |
| 91 | fatty acid transmembrane transport (GO:1902001) | 2.91004967 |
| 92 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.89904665 |
| 93 | regulation of myoblast differentiation (GO:0045661) | 2.87961129 |
| 94 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.87084833 |
| 95 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.87084833 |
| 96 | regulation of muscle contraction (GO:0006937) | 2.87005104 |
| 97 | glucan catabolic process (GO:0009251) | 2.85462773 |
| 98 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.84897734 |
| 99 | muscle tissue development (GO:0060537) | 2.84707949 |
| 100 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.81697846 |
| 101 | regulation of cardiac muscle contraction (GO:0055117) | 2.81516232 |
| 102 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.77022757 |
| 103 | muscle cell cellular homeostasis (GO:0046716) | 2.76054665 |
| 104 | positive regulation of cation channel activity (GO:2001259) | 2.75890050 |
| 105 | striated muscle cell development (GO:0055002) | 2.74899231 |
| 106 | ensheathment of neurons (GO:0007272) | 2.74895878 |
| 107 | axon ensheathment (GO:0008366) | 2.74895878 |
| 108 | regulation of membrane repolarization (GO:0060306) | 2.74623634 |
| 109 | relaxation of cardiac muscle (GO:0055119) | 2.74253518 |
| 110 | myelination (GO:0042552) | 2.73912495 |
| 111 | regulation of the force of heart contraction (GO:0002026) | 2.73599809 |
| 112 | regulation of somitogenesis (GO:0014807) | 2.71918168 |
| 113 | fibroblast migration (GO:0010761) | 2.69832906 |
| 114 | muscle adaptation (GO:0043500) | 2.68860447 |
| 115 | carnitine transmembrane transport (GO:1902603) | 2.68743380 |
| 116 | NADH metabolic process (GO:0006734) | 2.67407213 |
| 117 | cellular polysaccharide catabolic process (GO:0044247) | 2.65143501 |
| 118 | cellular response to epinephrine stimulus (GO:0071872) | 2.61902443 |
| 119 | regulation of muscle system process (GO:0090257) | 2.61286131 |
| 120 | muscle structure development (GO:0061061) | 2.60819252 |
| 121 | relaxation of muscle (GO:0090075) | 2.59953326 |
| 122 | response to epinephrine (GO:0071871) | 2.59767371 |
| 123 | cardiac muscle cell action potential (GO:0086001) | 2.57020797 |
| 124 | positive regulation of heart rate (GO:0010460) | 2.55925362 |
| 125 | respiratory electron transport chain (GO:0022904) | 2.55804357 |
| 126 | cell communication involved in cardiac conduction (GO:0086065) | 2.55660577 |
| 127 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.55570118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.87960884 |
| 2 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.73816724 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.72286942 |
| 4 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.48226002 |
| 5 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.30620512 |
| 6 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.10855924 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.06515613 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.95486315 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.91343755 |
| 10 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.81998412 |
| 11 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.81998412 |
| 12 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.79751178 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.76917541 |
| 14 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.76272583 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.75085638 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.66585222 |
| 17 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.66579783 |
| 18 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.66579783 |
| 19 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.66447931 |
| 20 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64227399 |
| 21 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.62968569 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.62838850 |
| 23 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.56973035 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.54749222 |
| 25 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.54204607 |
| 26 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.52631790 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.52315470 |
| 28 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.50878614 |
| 29 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.50623522 |
| 30 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49594567 |
| 31 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.48543257 |
| 32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.48540161 |
| 33 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.48468352 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.46652553 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45935138 |
| 36 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45245576 |
| 37 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.44318589 |
| 38 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.44318589 |
| 39 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.42850648 |
| 40 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41978515 |
| 41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.40471348 |
| 42 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.39156332 |
| 43 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.38908101 |
| 44 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.38380224 |
| 45 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.36910128 |
| 46 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.36342147 |
| 47 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.35845493 |
| 48 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.35114050 |
| 49 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.34968743 |
| 50 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.34242115 |
| 51 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.30686369 |
| 52 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.30382066 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30243961 |
| 54 | VDR_22108803_ChIP-Seq_LS180_Human | 1.29280674 |
| 55 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.27988162 |
| 56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27812477 |
| 57 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.27665770 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25885304 |
| 59 | * TP53_16413492_ChIP-PET_HCT116_Human | 1.25204340 |
| 60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24582749 |
| 61 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.24135229 |
| 62 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.23377384 |
| 63 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.23171489 |
| 64 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22896002 |
| 65 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.21844787 |
| 66 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.21806548 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.20987972 |
| 68 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.20979740 |
| 69 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.20683895 |
| 70 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.19355309 |
| 71 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.19264015 |
| 72 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17529482 |
| 73 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17101836 |
| 74 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.16758684 |
| 75 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.15686639 |
| 76 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.15053377 |
| 77 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.15053377 |
| 78 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13731455 |
| 79 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.13215963 |
| 80 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12740640 |
| 81 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.10734101 |
| 82 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09900806 |
| 83 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09232381 |
| 84 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.07885603 |
| 85 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06982320 |
| 86 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05801125 |
| 87 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04911006 |
| 88 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03767068 |
| 89 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.02413380 |
| 90 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.01678569 |
| 91 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.01210359 |
| 92 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01200456 |
| 93 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01053917 |
| 94 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00727698 |
| 95 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00568534 |
| 96 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.99889412 |
| 97 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99690263 |
| 98 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.99623499 |
| 99 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98371995 |
| 100 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98161457 |
| 101 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97953239 |
| 102 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97904909 |
| 103 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.97874139 |
| 104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97608510 |
| 105 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.96998269 |
| 106 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.95517990 |
| 107 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95366864 |
| 108 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95359466 |
| 109 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95065434 |
| 110 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94341192 |
| 111 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.93830902 |
| 112 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.93744539 |
| 113 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.93408924 |
| 114 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92567472 |
| 115 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.92422984 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91586582 |
| 117 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90922992 |
| 118 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89143428 |
| 119 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.87832756 |
| 120 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87824526 |
| 121 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87699130 |
| 122 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.87680020 |
| 123 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.87564886 |
| 124 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.86537776 |
| 125 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.85463420 |
| 126 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.85114299 |
| 127 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.84732694 |
| 128 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83288281 |
| 129 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.83082919 |
| 130 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.83056680 |
| 131 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82816775 |
| 132 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.82368469 |
| 133 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.81976496 |
| 134 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.81828877 |
| 135 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.81637365 |
| 136 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81514896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000749_muscle_degeneration | 4.77912031 |
| 2 | MP0004145_abnormal_muscle_electrophysio | 4.71555827 |
| 3 | MP0000751_myopathy | 4.60969764 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 4.26230638 |
| 5 | MP0003646_muscle_fatigue | 4.04807843 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.92997769 |
| 7 | MP0004084_abnormal_cardiac_muscle | 3.56659905 |
| 8 | MP0004087_abnormal_muscle_fiber | 2.96379093 |
| 9 | * MP0002106_abnormal_muscle_physiology | 2.85129389 |
| 10 | MP0005330_cardiomyopathy | 2.84809398 |
| 11 | MP0005620_abnormal_muscle_contractility | 2.76535442 |
| 12 | MP0004215_abnormal_myocardial_fiber | 2.75916327 |
| 13 | MP0000747_muscle_weakness | 2.65283805 |
| 14 | MP0000759_abnormal_skeletal_muscle | 2.51031134 |
| 15 | * MP0005369_muscle_phenotype | 2.45875374 |
| 16 | MP0000750_abnormal_muscle_regeneration | 2.45709336 |
| 17 | MP0002972_abnormal_cardiac_muscle | 2.37807776 |
| 18 | MP0004130_abnormal_muscle_cell | 2.36327089 |
| 19 | MP0003950_abnormal_plasma_membrane | 2.26951625 |
| 20 | * MP0002269_muscular_atrophy | 2.01956754 |
| 21 | MP0001485_abnormal_pinna_reflex | 2.01194278 |
| 22 | MP0003137_abnormal_impulse_conducting | 1.93087407 |
| 23 | MP0004484_altered_response_of | 1.89561826 |
| 24 | MP0010630_abnormal_cardiac_muscle | 1.81580895 |
| 25 | MP0005377_hearing/vestibular/ear_phenot | 1.72734192 |
| 26 | MP0003878_abnormal_ear_physiology | 1.72734192 |
| 27 | MP0008775_abnormal_heart_ventricle | 1.69706969 |
| 28 | MP0005670_abnormal_white_adipose | 1.67457453 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 1.62201108 |
| 30 | MP0000762_abnormal_tongue_morphology | 1.60482110 |
| 31 | MP0002108_abnormal_muscle_morphology | 1.58153760 |
| 32 | MP0005385_cardiovascular_system_phenoty | 1.57671859 |
| 33 | MP0001544_abnormal_cardiovascular_syste | 1.57671859 |
| 34 | MP0000733_abnormal_muscle_development | 1.50536831 |
| 35 | MP0003828_pulmonary_edema | 1.44463765 |
| 36 | MP0004085_abnormal_heartbeat | 1.40704690 |
| 37 | MP0000920_abnormal_myelination | 1.37272101 |
| 38 | MP0006138_congestive_heart_failure | 1.35842136 |
| 39 | MP0004510_myositis | 1.34429643 |
| 40 | MP0002332_abnormal_exercise_endurance | 1.31502056 |
| 41 | MP0001661_extended_life_span | 1.29476313 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.27860349 |
| 43 | MP0002009_preneoplasia | 1.24781839 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.20102463 |
| 45 | MP0000383_abnormal_hair_follicle | 1.16468790 |
| 46 | MP0001958_emphysema | 1.15758895 |
| 47 | MP0003221_abnormal_cardiomyocyte_apopto | 1.14433390 |
| 48 | MP0004233_abnormal_muscle_weight | 1.13167866 |
| 49 | MP0005275_abnormal_skin_tensile | 1.12055970 |
| 50 | MP0010678_abnormal_skin_adnexa | 1.11819364 |
| 51 | MP0009250_abnormal_appendicular_skeleto | 1.11074166 |
| 52 | MP0002234_abnormal_pharynx_morphology | 1.10305262 |
| 53 | MP0004134_abnormal_chest_morphology | 1.05120688 |
| 54 | MP0005666_abnormal_adipose_tissue | 1.03941023 |
| 55 | MP0001346_abnormal_lacrimal_gland | 1.02911255 |
| 56 | MP0005171_absent_coat_pigmentation | 1.01728202 |
| 57 | MP0008789_abnormal_olfactory_epithelium | 1.01719601 |
| 58 | MP0004272_abnormal_basement_membrane | 1.01403944 |
| 59 | MP0004381_abnormal_hair_follicle | 0.99215306 |
| 60 | MP0000579_abnormal_nail_morphology | 0.97129466 |
| 61 | MP0003941_abnormal_skin_development | 0.96735706 |
| 62 | MP0002896_abnormal_bone_mineralization | 0.93807825 |
| 63 | MP0005375_adipose_tissue_phenotype | 0.93800692 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 0.90772265 |
| 65 | MP0001299_abnormal_eye_distance/ | 0.90539200 |
| 66 | MP0003091_abnormal_cell_migration | 0.89020688 |
| 67 | MP0003566_abnormal_cell_adhesion | 0.88937885 |
| 68 | MP0002127_abnormal_cardiovascular_syste | 0.87646483 |
| 69 | MP0001879_abnormal_lymphatic_vessel | 0.87096298 |
| 70 | MP0000467_abnormal_esophagus_morphology | 0.85970141 |
| 71 | MP0005451_abnormal_body_composition | 0.84662826 |
| 72 | MP0008438_abnormal_cutaneous_collagen | 0.84297059 |
| 73 | MP0004147_increased_porphyrin_level | 0.83639170 |
| 74 | MP0002971_abnormal_brown_adipose | 0.83237649 |
| 75 | MP0010368_abnormal_lymphatic_system | 0.82847416 |
| 76 | MP0005023_abnormal_wound_healing | 0.81496902 |
| 77 | MP0002254_reproductive_system_inflammat | 0.79734809 |
| 78 | MP0009384_cardiac_valve_regurgitation | 0.79568344 |
| 79 | MP0004742_abnormal_vestibular_system | 0.79560945 |
| 80 | MP0004270_analgesia | 0.77789713 |
| 81 | MP0002168_other_aberrant_phenotype | 0.77671971 |
| 82 | MP0005499_abnormal_olfactory_system | 0.76905179 |
| 83 | MP0005394_taste/olfaction_phenotype | 0.76905179 |
| 84 | MP0002877_abnormal_melanocyte_morpholog | 0.76362458 |
| 85 | MP0003879_abnormal_hair_cell | 0.75877942 |
| 86 | MP0000566_synostosis | 0.75215691 |
| 87 | MP0000003_abnormal_adipose_tissue | 0.73333668 |
| 88 | MP0005266_abnormal_metabolism | 0.72184251 |
| 89 | MP0003136_yellow_coat_color | 0.71945729 |
| 90 | MP0002128_abnormal_blood_circulation | 0.71045673 |
| 91 | MP0005595_abnormal_vascular_smooth | 0.70292902 |
| 92 | MP0000026_abnormal_inner_ear | 0.69194669 |
| 93 | MP0002796_impaired_skin_barrier | 0.68810916 |
| 94 | MP0005623_abnormal_meninges_morphology | 0.68749025 |
| 95 | MP0010030_abnormal_orbit_morphology | 0.68591209 |
| 96 | MP0001849_ear_inflammation | 0.67654102 |
| 97 | MP0005165_increased_susceptibility_to | 0.65595639 |
| 98 | MP0004043_abnormal_pH_regulation | 0.65545796 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.64695451 |
| 100 | MP0002098_abnormal_vibrissa_morphology | 0.64626483 |
| 101 | MP0000266_abnormal_heart_morphology | 0.62899248 |
| 102 | MP0003045_fibrosis | 0.61867431 |
| 103 | MP0000013_abnormal_adipose_tissue | 0.61171767 |
| 104 | MP0000049_abnormal_middle_ear | 0.60288072 |
| 105 | MP0004885_abnormal_endolymph | 0.60032003 |
| 106 | MP0000372_irregular_coat_pigmentation | 0.59339457 |
| 107 | MP0001963_abnormal_hearing_physiology | 0.58547914 |
| 108 | MP0001486_abnormal_startle_reflex | 0.58536645 |
| 109 | MP0003385_abnormal_body_wall | 0.58188301 |
| 110 | MP0005409_darkened_coat_color | 0.58125218 |
| 111 | MP0005503_abnormal_tendon_morphology | 0.58115631 |
| 112 | MP0000647_abnormal_sebaceous_gland | 0.57305862 |
| 113 | MP0002060_abnormal_skin_morphology | 0.57224043 |
| 114 | MP0002233_abnormal_nose_morphology | 0.56834335 |
| 115 | MP0003567_abnormal_fetal_cardiomyocyte | 0.56652248 |
| 116 | MP0000767_abnormal_smooth_muscle | 0.56574482 |
| 117 | MP0003279_aneurysm | 0.56431428 |
| 118 | MP0000462_abnormal_digestive_system | 0.56412880 |
| 119 | MP0000343_altered_response_to | 0.55457530 |
| 120 | MP0002933_joint_inflammation | 0.55151670 |
| 121 | MP0005508_abnormal_skeleton_morphology | 0.54568540 |
| 122 | MP0001502_abnormal_circadian_rhythm | 0.45608525 |
| 123 | MP0000534_abnormal_ureter_morphology | 0.43240952 |
| 124 | MP0003011_delayed_dark_adaptation | 0.42699052 |
| 125 | MP0002295_abnormal_pulmonary_circulatio | 0.42577794 |
| 126 | MP0002114_abnormal_axial_skeleton | 0.41898888 |
| 127 | MP0005164_abnormal_response_to | 0.38762832 |
| 128 | MP0008569_lethality_at_weaning | 0.38136903 |
| 129 | MP0002998_abnormal_bone_remodeling | 0.36944656 |
| 130 | MP0005166_decreased_susceptibility_to | 0.35557063 |
| 131 | MP0001614_abnormal_blood_vessel | 0.34556683 |
| 132 | MP0005257_abnormal_intraocular_pressure | 0.33664990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.04027272 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 6.92850773 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 6.90162612 |
| 4 | Exercise-induced myalgia (HP:0003738) | 6.86530757 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.80498569 |
| 6 | Nemaline bodies (HP:0003798) | 6.29080761 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 6.22730391 |
| 8 | Muscle fiber splitting (HP:0003555) | 5.80681516 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 5.66589315 |
| 10 | Type 1 muscle fiber predominance (HP:0003803) | 5.21631562 |
| 11 | Sudden death (HP:0001699) | 5.14609393 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 5.12066047 |
| 13 | Ventricular tachycardia (HP:0004756) | 4.76898794 |
| 14 | EMG: myopathic abnormalities (HP:0003458) | 4.54494437 |
| 15 | Difficulty running (HP:0009046) | 4.44048906 |
| 16 | Right ventricular cardiomyopathy (HP:0011663) | 4.28937599 |
| 17 | Distal arthrogryposis (HP:0005684) | 4.14330991 |
| 18 | Myoglobinuria (HP:0002913) | 4.13726597 |
| 19 | Round ear (HP:0100830) | 3.95161009 |
| 20 | Subaortic stenosis (HP:0001682) | 3.85123788 |
| 21 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.85123788 |
| 22 | Myopathic facies (HP:0002058) | 3.78948693 |
| 23 | Atrial fibrillation (HP:0005110) | 3.68765762 |
| 24 | Increased connective tissue (HP:0009025) | 3.55272730 |
| 25 | Lipoatrophy (HP:0100578) | 3.46990678 |
| 26 | Neck muscle weakness (HP:0000467) | 3.46318759 |
| 27 | Primary atrial arrhythmia (HP:0001692) | 3.37730055 |
| 28 | Aortic aneurysm (HP:0004942) | 3.35928920 |
| 29 | Muscle stiffness (HP:0003552) | 3.28994576 |
| 30 | Dilated cardiomyopathy (HP:0001644) | 3.24871872 |
| 31 | Supraventricular tachycardia (HP:0004755) | 3.22828987 |
| 32 | Supraventricular arrhythmia (HP:0005115) | 3.14305800 |
| 33 | Myotonia (HP:0002486) | 3.13487613 |
| 34 | Distal lower limb muscle weakness (HP:0009053) | 3.03303691 |
| 35 | Rhabdomyolysis (HP:0003201) | 3.00320776 |
| 36 | Ulnar deviation of the wrist (HP:0003049) | 2.87071432 |
| 37 | Syncope (HP:0001279) | 2.83839206 |
| 38 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.83554718 |
| 39 | Absent phalangeal crease (HP:0006109) | 2.83202995 |
| 40 | Hypoplastic ischia (HP:0003175) | 2.81251076 |
| 41 | Rimmed vacuoles (HP:0003805) | 2.79319689 |
| 42 | Slender build (HP:0001533) | 2.79236712 |
| 43 | Prolonged QT interval (HP:0001657) | 2.77926172 |
| 44 | Scapular winging (HP:0003691) | 2.77804874 |
| 45 | Increased variability in muscle fiber diameter (HP:0003557) | 2.73393781 |
| 46 | Gowers sign (HP:0003391) | 2.64636303 |
| 47 | Areflexia of lower limbs (HP:0002522) | 2.63904307 |
| 48 | Calcaneovalgus deformity (HP:0001848) | 2.60021755 |
| 49 | Asymmetric septal hypertrophy (HP:0001670) | 2.57619076 |
| 50 | Ventricular arrhythmia (HP:0004308) | 2.56614153 |
| 51 | Abnormality of the ischium (HP:0003174) | 2.54480488 |
| 52 | Difficulty climbing stairs (HP:0003551) | 2.52731024 |
| 53 | Fatigable weakness (HP:0003473) | 2.47981667 |
| 54 | Abnormality of the neuromuscular junction (HP:0003398) | 2.47981667 |
| 55 | Popliteal pterygium (HP:0009756) | 2.46690708 |
| 56 | Palpitations (HP:0001962) | 2.45093215 |
| 57 | Deformed tarsal bones (HP:0008119) | 2.43482794 |
| 58 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.42130007 |
| 59 | Fetal akinesia sequence (HP:0001989) | 2.40338343 |
| 60 | Bundle branch block (HP:0011710) | 2.40029415 |
| 61 | Aortic dissection (HP:0002647) | 2.39667340 |
| 62 | Weak cry (HP:0001612) | 2.39388052 |
| 63 | Abnormal finger flexion creases (HP:0006143) | 2.37394765 |
| 64 | Muscular dystrophy (HP:0003560) | 2.36016461 |
| 65 | Hyperkalemia (HP:0002153) | 2.26778255 |
| 66 | Foot dorsiflexor weakness (HP:0009027) | 2.22930706 |
| 67 | Heart block (HP:0012722) | 2.20089497 |
| 68 | Abnormal atrioventricular conduction (HP:0005150) | 2.16657910 |
| 69 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.16503568 |
| 70 | Abnormality of the foot musculature (HP:0001436) | 2.13862943 |
| 71 | Distal lower limb amyotrophy (HP:0008944) | 2.11024316 |
| 72 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.08025246 |
| 73 | Lip pit (HP:0100267) | 2.04540664 |
| 74 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.03457665 |
| 75 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.03457665 |
| 76 | Limited hip movement (HP:0008800) | 2.02840707 |
| 77 | Limb-girdle muscle weakness (HP:0003325) | 2.02737515 |
| 78 | Generalized muscle weakness (HP:0003324) | 2.02648266 |
| 79 | Facial diplegia (HP:0001349) | 1.99520466 |
| 80 | Waddling gait (HP:0002515) | 1.97939838 |
| 81 | Nonprogressive disorder (HP:0003680) | 1.97164248 |
| 82 | Palmoplantar keratoderma (HP:0000982) | 1.96533707 |
| 83 | Protrusio acetabuli (HP:0003179) | 1.94320023 |
| 84 | Spinal rigidity (HP:0003306) | 1.93251092 |
| 85 | Limb-girdle muscle atrophy (HP:0003797) | 1.93154131 |
| 86 | Cerebral aneurysm (HP:0004944) | 1.92622713 |
| 87 | Periauricular skin pits (HP:0100277) | 1.91731914 |
| 88 | Preauricular pit (HP:0004467) | 1.91731914 |
| 89 | Malignant hyperthermia (HP:0002047) | 1.91467731 |
| 90 | Bulbar palsy (HP:0001283) | 1.89395524 |
| 91 | Bell-shaped thorax (HP:0001591) | 1.87199248 |
| 92 | Left ventricular hypertrophy (HP:0001712) | 1.86610315 |
| 93 | Abnormal EKG (HP:0003115) | 1.86454368 |
| 94 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.84595058 |
| 95 | Hip contracture (HP:0003273) | 1.83414296 |
| 96 | Lower limb amyotrophy (HP:0007210) | 1.80683481 |
| 97 | Atrioventricular block (HP:0001678) | 1.78658580 |
| 98 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.76186954 |
| 99 | Acute necrotizing encephalopathy (HP:0006965) | 1.75655197 |
| 100 | Proximal amyotrophy (HP:0007126) | 1.75481499 |
| 101 | Ventricular fibrillation (HP:0001663) | 1.75391433 |
| 102 | Broad metatarsal (HP:0001783) | 1.73883240 |
| 103 | Frequent falls (HP:0002359) | 1.72004290 |
| 104 | Aplasia cutis congenita (HP:0001057) | 1.68390233 |
| 105 | Atrophic scars (HP:0001075) | 1.68357261 |
| 106 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.67441711 |
| 107 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.67441711 |
| 108 | Hypoplasia of the iris (HP:0007676) | 1.65920148 |
| 109 | EMG: neuropathic changes (HP:0003445) | 1.65733657 |
| 110 | Steppage gait (HP:0003376) | 1.65726090 |
| 111 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.64164774 |
| 112 | Arterial tortuosity (HP:0005116) | 1.63943428 |
| 113 | Long clavicles (HP:0000890) | 1.62176360 |
| 114 | Vascular tortuosity (HP:0004948) | 1.61373135 |
| 115 | Aneurysm (HP:0002617) | 1.57651668 |
| 116 | Abnormality of the calcaneus (HP:0008364) | 1.55717696 |
| 117 | Aplasia of the musculature (HP:0100854) | 1.52176923 |
| 118 | Oligomenorrhea (HP:0000876) | 1.49169346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.70899040 |
| 2 | TTN | 4.98014107 |
| 3 | PHKG2 | 3.87366362 |
| 4 | PHKG1 | 3.87366362 |
| 5 | STK39 | 3.33071189 |
| 6 | PIK3CA | 2.76156163 |
| 7 | DMPK | 2.72113675 |
| 8 | EPHB1 | 2.65399714 |
| 9 | MYLK | 2.55457315 |
| 10 | PIK3CG | 2.11398472 |
| 11 | MUSK | 2.03576771 |
| 12 | TRPM7 | 1.98437344 |
| 13 | NME1 | 1.90156896 |
| 14 | ZAK | 1.82244528 |
| 15 | OXSR1 | 1.63605813 |
| 16 | PKN1 | 1.50804680 |
| 17 | MAP3K7 | 1.42818633 |
| 18 | PINK1 | 1.39393526 |
| 19 | LIMK1 | 1.36432450 |
| 20 | PAK3 | 1.33019596 |
| 21 | CAMK2D | 1.31264292 |
| 22 | LMTK2 | 1.27628565 |
| 23 | WNK4 | 1.27078536 |
| 24 | ERBB3 | 1.25144602 |
| 25 | WNK1 | 1.16046639 |
| 26 | MST4 | 1.11930823 |
| 27 | MAP2K3 | 1.11109487 |
| 28 | MARK1 | 1.09139917 |
| 29 | INSRR | 1.08955570 |
| 30 | FER | 1.05936209 |
| 31 | ROCK2 | 1.02966689 |
| 32 | PRKD1 | 1.02349543 |
| 33 | PDK2 | 1.01642875 |
| 34 | PDK3 | 0.98595974 |
| 35 | PDK4 | 0.98595974 |
| 36 | LATS2 | 0.97245357 |
| 37 | MAPK15 | 0.94508519 |
| 38 | BCR | 0.92739364 |
| 39 | MET | 0.92574129 |
| 40 | MAP3K3 | 0.91654049 |
| 41 | ROCK1 | 0.90418099 |
| 42 | CAMK2G | 0.89304218 |
| 43 | TNIK | 0.87256117 |
| 44 | GRK7 | 0.87119654 |
| 45 | PDGFRA | 0.86600869 |
| 46 | DDR2 | 0.82958091 |
| 47 | MAPK12 | 0.80868626 |
| 48 | PTK2 | 0.80630377 |
| 49 | MOS | 0.80200776 |
| 50 | TRIB3 | 0.78842515 |
| 51 | PRKAA2 | 0.78761457 |
| 52 | SGK3 | 0.77069082 |
| 53 | PAK2 | 0.75308517 |
| 54 | LATS1 | 0.74197546 |
| 55 | AKT3 | 0.73931841 |
| 56 | STK38L | 0.72660832 |
| 57 | EEF2K | 0.72332536 |
| 58 | NEK6 | 0.67877081 |
| 59 | PBK | 0.66836734 |
| 60 | CAMK2B | 0.66486592 |
| 61 | MAPKAPK5 | 0.65271764 |
| 62 | STK38 | 0.64233864 |
| 63 | EPHA3 | 0.64162669 |
| 64 | MAP3K6 | 0.63137440 |
| 65 | BCKDK | 0.63125803 |
| 66 | SGK2 | 0.62653337 |
| 67 | MAPK4 | 0.61114725 |
| 68 | CAMK2A | 0.60693593 |
| 69 | PRKCE | 0.60421852 |
| 70 | TESK1 | 0.60084868 |
| 71 | STK24 | 0.59895093 |
| 72 | TIE1 | 0.58854159 |
| 73 | JAK1 | 0.56295027 |
| 74 | CDK19 | 0.55712373 |
| 75 | NLK | 0.55507111 |
| 76 | SIK1 | 0.54923016 |
| 77 | CLK1 | 0.54134407 |
| 78 | MTOR | 0.53952315 |
| 79 | ILK | 0.52350897 |
| 80 | PRPF4B | 0.52344573 |
| 81 | PTK2B | 0.51107695 |
| 82 | BMPR2 | 0.50976310 |
| 83 | CDC42BPA | 0.49441495 |
| 84 | MAP3K13 | 0.48923547 |
| 85 | EPHA2 | 0.48896061 |
| 86 | CAMK1G | 0.47103605 |
| 87 | EPHB2 | 0.45563749 |
| 88 | FGFR2 | 0.45309293 |
| 89 | PRKAA1 | 0.43747504 |
| 90 | MAP2K6 | 0.43552232 |
| 91 | IRAK1 | 0.43421852 |
| 92 | CAMK1 | 0.41575807 |
| 93 | PRKACB | 0.41323774 |
| 94 | PRKG1 | 0.41123603 |
| 95 | STK4 | 0.40552373 |
| 96 | PDGFRB | 0.36953198 |
| 97 | MAP2K4 | 0.36718790 |
| 98 | MAPK7 | 0.36411380 |
| 99 | PRKACA | 0.36146907 |
| 100 | MARK2 | 0.35648064 |
| 101 | SGK223 | 0.34982576 |
| 102 | SGK494 | 0.34982576 |
| 103 | MAPK11 | 0.34852786 |
| 104 | UHMK1 | 0.34664244 |
| 105 | PRKCQ | 0.33944413 |
| 106 | NUAK1 | 0.33504184 |
| 107 | FGFR3 | 0.33445110 |
| 108 | RIPK1 | 0.31736975 |
| 109 | TBK1 | 0.31614611 |
| 110 | ICK | 0.31267117 |
| 111 | PRKD2 | 0.31255250 |
| 112 | RPS6KA2 | 0.30289280 |
| 113 | HIPK2 | 0.28749387 |
| 114 | TGFBR2 | 0.28171694 |
| 115 | SGK1 | 0.27933803 |
| 116 | AKT2 | 0.27608705 |
| 117 | CCNB1 | 0.27524109 |
| 118 | MAPKAPK3 | 0.27324710 |
| 119 | MELK | 0.27132849 |
| 120 | MAP3K12 | 0.26376461 |
| 121 | MARK3 | 0.26313272 |
| 122 | PAK6 | 0.25660838 |
| 123 | ADRBK1 | 0.25271597 |
| 124 | CSNK1A1L | 0.25176851 |
| 125 | MST1R | 0.25158210 |
| 126 | NEK9 | 0.23288158 |
| 127 | IRAK2 | 0.22945224 |
| 128 | RPS6KA3 | 0.22642720 |
| 129 | GSK3A | 0.22279957 |
| 130 | MAP2K1 | 0.21894354 |
| 131 | FRK | 0.21814231 |
| 132 | CAMK4 | 0.21792403 |
| 133 | PDPK1 | 0.21684915 |
| 134 | PKN2 | 0.21680494 |
| 135 | MAPK10 | 0.21599471 |
| 136 | MAP3K1 | 0.20521877 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.11796428 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.82943889 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.79802481 |
| 4 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.46557840 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.69788608 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.45529258 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.37541997 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.19483771 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.15496633 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.01252334 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94817524 |
| 12 | Tight junction_Homo sapiens_hsa04530 | 1.93762000 |
| 13 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.78346638 |
| 14 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.65840306 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.51404080 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.47782852 |
| 17 | Focal adhesion_Homo sapiens_hsa04510 | 1.35578555 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.33601402 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.26966120 |
| 20 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26289461 |
| 21 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.25901055 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.25115818 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.22939584 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.21538684 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15430129 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.14563599 |
| 27 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.12494372 |
| 28 | Adherens junction_Homo sapiens_hsa04520 | 1.11524576 |
| 29 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.10918940 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.09825201 |
| 31 | Circadian rhythm_Homo sapiens_hsa04710 | 1.04885835 |
| 32 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.04169314 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.02754491 |
| 34 | Insulin resistance_Homo sapiens_hsa04931 | 0.99494534 |
| 35 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.98963786 |
| 36 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.97478668 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.96916423 |
| 38 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96146703 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.92953100 |
| 40 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.92900495 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 0.89333647 |
| 42 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88509361 |
| 43 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.86892349 |
| 44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86080477 |
| 45 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.85446729 |
| 46 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82908794 |
| 47 | Long-term potentiation_Homo sapiens_hsa04720 | 0.82416392 |
| 48 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.82113662 |
| 49 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.81587642 |
| 50 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80582180 |
| 51 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.80115733 |
| 52 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.79529683 |
| 53 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.79118959 |
| 54 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76600160 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75834928 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.75117627 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74201582 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.73523799 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 0.72656654 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70721224 |
| 61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.70066351 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.69873495 |
| 63 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.69631406 |
| 64 | Renin secretion_Homo sapiens_hsa04924 | 0.68912760 |
| 65 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.68749721 |
| 66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67891733 |
| 67 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.65908773 |
| 68 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64823339 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64537970 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63746501 |
| 71 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.62300703 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62296246 |
| 73 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.61737283 |
| 74 | Glioma_Homo sapiens_hsa05214 | 0.61463471 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60209717 |
| 76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59395259 |
| 77 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.58611136 |
| 78 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58604042 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58106134 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57254921 |
| 81 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.56895917 |
| 82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56538318 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.56405305 |
| 84 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.55921043 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.55707180 |
| 86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54570582 |
| 87 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.54368837 |
| 88 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.53509690 |
| 89 | Lysine degradation_Homo sapiens_hsa00310 | 0.52582143 |
| 90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52482922 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.52299922 |
| 92 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.52010941 |
| 93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51580583 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49937576 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48370241 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48224472 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47744789 |
| 98 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47430899 |
| 99 | Melanoma_Homo sapiens_hsa05218 | 0.46685974 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45979017 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45357811 |
| 102 | Platelet activation_Homo sapiens_hsa04611 | 0.44724991 |
| 103 | Salivary secretion_Homo sapiens_hsa04970 | 0.44265067 |
| 104 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43988762 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43713086 |
| 106 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.43437504 |
| 107 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42529328 |
| 108 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.41882263 |
| 109 | Gap junction_Homo sapiens_hsa04540 | 0.41558727 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41290836 |
| 111 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.41068050 |
| 112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40510322 |
| 113 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.40274662 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.40231650 |
| 115 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39350329 |
| 116 | Melanogenesis_Homo sapiens_hsa04916 | 0.38538918 |
| 117 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.37900311 |
| 118 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.37852428 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37384480 |
| 120 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.37324561 |
| 121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36960809 |
| 122 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.36552794 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.36384345 |
| 124 | Long-term depression_Homo sapiens_hsa04730 | 0.35585738 |
| 125 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35270372 |
| 126 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34575666 |
| 127 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.33953709 |
| 128 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.33748651 |
| 129 | Circadian entrainment_Homo sapiens_hsa04713 | 0.33060492 |
| 130 | Bile secretion_Homo sapiens_hsa04976 | 0.32653246 |
| 131 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32213755 |
| 132 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31821827 |
| 133 | Histidine metabolism_Homo sapiens_hsa00340 | 0.31652773 |
| 134 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.31269256 |
| 135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31266701 |
| 136 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.30295114 |
| 137 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.29536925 |
| 138 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.29310848 |
| 139 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28670939 |
| 140 | Pathways in cancer_Homo sapiens_hsa05200 | 0.28557937 |
| 141 | Insulin secretion_Homo sapiens_hsa04911 | 0.27191498 |
| 142 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26911507 |

